Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00716157 · ClinicalTrials.gov registry record
Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation
A clinical trial, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 40
- Enrollment target
NCT00716157 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 40 participants.
The verdict
NCT00716157 has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
Questionnaire study to observe the incidence and pattern or nausea and vomiting in patients receiving combined chemotherapy and radiation. 83% of patients experience radiation therapy-induced vomiting; significant nausea and vomiting could develop with concurrent chemotherapy despite standard anti-nauseous medication prophylaxis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2004-10 |
| Est. Completion | 2011-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00716157
The ClinicalTrials.gov registry entry for NCT00716157 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00716157 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00716157 about?
NCT00716157 is a clinical study titled "Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation". Questionnaire study to observe the incidence and pattern or nausea and vomiting in patients receiving combined chemotherapy and radiation. 83% of patients experience radiation therapy-induced vomiting; significant nausea and vomiting could develop with concurrent chemotherapy despite standard anti-n...
What is the current status of trial NCT00716157?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2004-10. Estimated completion is 2011-09.
Who is sponsoring clinical trial NCT00716157?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.